Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

ADR of Herbal Medicines

한약물의 ADR

  • Ko Seong-Gyu (Department of Internal Medicine, College of Oriental Medicine, Sangji University) ;
  • Jang Byoung Eun (Department of Internal Medicine, College of Oriental Medicine, Sangji University) ;
  • Choi Jae Sun (Department of Internal Medicine, College of Oriental Medicine, Sangji University)
  • 고성규 (상지대학교 한의과대학 내과) ;
  • 장병은 (상지대학교 한의과대학 내과) ;
  • 최재선 (상지대학교 한의과대학 내과)
  • Published : 2004.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Herbal medicines are increasingly used to treat various diseases and lots of studies have been reported that they had benefits in treating and preventing of diseases. But organic toxicity is increasingly recognized as herbal medicines become more popular in industrialized countries. Some herbal products potentially benefit people with lots of diseases, however these benefits remain generally unproved in humans, and a greater awareness for potential adverse effects is required. A herb containing a wide variety of, mostly unknown, substances may well include some with unwanted effects. This review focuses on emerging organic toxicities that have been observed associated with various herbal preparations involving the liver, kidney, and heart, and patterns of organ injury, potential risk factors for organic toxicities. In addition to the potential for organic toxicities, drug drug interactions between herbal medicines and conventional agents may affect the efficacy and safety of concurrent medical therapy. Appropriate reporting and regulatory system to monitor herbal toxicity are required, in conjunction with ongoing scientific evaluation of the potential benefits of phytotherapy.

Keywords

References

  1. Life Science v.74 Herbal bioactivation: The good, the bad and the ugly Zhou S;Koh HL;Gao Y;Gong ZY;Edmund Jon Deoon Lee
  2. 한약급여시 의료시장 변화분석연구 보건사회연구원
  3. Am J Surg. v.179 no.5 A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites Morris KT;Johnson N;Homer L;Walts D.
  4. 식이유래 독성간염의 진단 및 보고체계 구축을 위한 다기관 예비연구 김동준
  5. Drug Safety v.13 no.2 Health risks of herbal remedies de Smet PA.
  6. Trends in pharmacological sciences v.23 no.3 Toxic heavy metals and undeclared drugs in Asian herbal medicines Ernst E.
  7. Med Clin North Am v.86 no.1 Herbal Medicine Ernst E;Pittler MH.
  8. Toxicology v.27 Clinical and laboratory investigations in herbal poisonings Deng JF
  9. American Journal of Health System Pharmacy v.56 no.2 Unsafe and potentially safe herbal therapies Klepsler TB;Klepser ME.
  10. Journal of Toxicology and Clinical Toxicology v.40 no.2 Development of a Chinese herbal medicine toxicology database Bensoussan A;Myers SP;Drew AK;Whyte IM;Dawson AH.
  11. Science v.288 Alternative medicine;Herbal product linked to cancer Greensfelder L.
  12. NEJM v.343 Adverse cardiovascular and central nervous system events associated with dietary supplements containg ephedra alkaloids Haller CA;Benowitz NL.
  13. NEJM v.342 Cancer and herbs Kessler DA.
  14. European Journal of Gastroenterology and Hepatology v.14 Hepatitis associated with Chinese herbs McRae CA;Agarwal K;Mutimer D;Bassendine MF.
  15. Seminars in Liver Disease v.22 no.2 Herbal hepatotoxicity C. Stedman
  16. Heart Diesase v.3 no.3 Adverse effects of herbal treatment of cardiovascular disease: what the physician must know Villegas JF;Barabe DN;Stein RA;Lazar E.
  17. J of Toxico and Clin Toxicol v.37 no.4 Hypersensitivity myocarditis associated with ephedra use Zaacks SM;Klein L;Tan CD;Rodriguez ER;Leikin JB.
  18. British J of Clin Pharmacology v.52 no.5 Herb drug interaction;review and assessment of report reliability Fugh Bermann A;Ernst E.
  19. Allergy v.58 Side effects of complementary and alternative medicine Niggemann B;Gruber C.
  20. Bull Environ Contam Toxicol v.66 Contamination of medicinal herbs with organophosporus insecticides Ahmed MT;Loutfy N;Yousef Y.
  21. Br Med J v.306 Arsenic and mercury intoxification due to Indian ethnic remedies Kew J;Morris C;Aihie A;Fysh R;Jones S;Brooks D.
  22. Am J Gastroenterol v.96 Fulminant exacerbation of autoimmune hepatitis after use of Ma Huang Borum ML.
  23. Am J Gastroenterol v.95 Cascara Sagradainduced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity Nadir A;Reddy D;Van Thiel DH
  24. Am J Gastroenterol v.92 Autoimmune hepatitis triggered by administration of an herbal medicine Kamiyama T;Nouchi T;Kojima S;Murata N;Ikeda T;Sato C.
  25. Dig Dis Sci v.40 Liver injuries induced by herbal medicine, Syo saiko to(xiao cha hu tang) Itoh S;Marutani K;Nishijama T;Matsuo S;Itabashi M.
  26. Ann Int Med v.121 Acute hepatitis associated with Chinese herbal product Jin Bu Huan Woolf GM;Petrovic LM;Rojter SE(et al.)
  27. Drug Saf v.17 Traditional remedies and food supplements: a five year toxicological study Shaw D;Leon C;Kolev S;Murray V.
  28. Lancet v.340 Toxicity of Chinese herbal remedies Perharic Walton L;Murray V.
  29. Gut v.36 Hepatitis induced by traditional Chinese herbs;possible toxic components Kane JA;Kane SP;Jain S.
  30. Am J Gastroenterol v.91 Chinese herbal medicine, fulminant hepatitis and liver transplantation(letter) Yoshida EM;McLean CA;Cheng ES(et al.)
  31. Med J Aust v.157 Adverse reaction to a Chinese herbal remedy Gorey JD;Wahlqvist ML;Boyce NW.
  32. Am J Gastroenterol v.91 Acute hepatitis associated with the use of a Chinese herbal product, Mahuang Nadir A;Agarwal S;King PD; Marshall JB.
  33. J Gastroentrol Hepatol no.Sup.15 Sho saiko to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma Shimizu I.
  34. BMJ v.199 Hepatotoxicity of herbal remedies MacGregor FB;Abernethy VE;Dahabra S(et al.)
  35. Gastroenterology v.117 Acute hepatitis induced by greater celandine(Chelidonium majus) Benninger J;Schneider HT;Schuppan D(et al.)
  36. Am J Gastroenterol v.92 Autoimmune hepatitis triggered by administration of an herbal medicine Kamiyama T;Nouchi T;Kojima S(et al.)
  37. J Hepatol v.28 Chronic hepatitis induced by Jin Bu Huan Picciotto A;Campo N;Brizzolara R(et al.)
  38. Ann Intern Med v.121 Acute hepatitis associated with the Chinese herbal product Jin Bu Huan Woolf GM;Petrovic LM;Rojter SE(et al.)
  39. Am J Gastroenterol v.91 Acute hepatitis associated with the use of a Chinese herbal product, Mahuang Nadir A;Agarwal S;King PD;Marshall JB.
  40. Current Hepatology. v.16 Drug induced liver disease Farrell GC;Weltman M;Gitnick G (ed.)
  41. Public Health Nutr v.3 Hepatotoxicity of botanicals Stickel F;Egerer G;Seitz HK.
  42. Am J Med v.106 Herbal toxicity and fatal hepatic failure Hullar TE;Sapers BL;Ridker PM(et al.)
  43. Kidney Int v.45 Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Cosyns JP;Jadoul M;Squiet JP;De Plaen JF;Ferluga D;de Van Ypersele Strihou C.
  44. Am J Kidney Dis v.24 Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs Depierreux M;Van Damme B;Vanden Houte K;Vanherweghem JL.
  45. NEJM v.342 no.23 Urothelial carcinoma associated with the use of a Chinese herb(Aristolochia fangchi) Nortier JL;Martinez MC;Schmeiser HH;Arlt VM;Bieler CA;Petein M; Depierreux MF; De Pauw L;Abramowicz D;Vereerstraeten P;Vanherweghem JL.
  46. NEJM v.343 no.25 Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids Haller CA;Benowitz NL
  47. Clin Pharmacol Ther v.71 Effect of St John’s wort on the pharmacokinetics of fexofenadine Wang Z;Hamman MA;Huang SM;Lesko LJ;Hall SD.
  48. J Hepato v.33 Interaction of Hypericum perforatum (St John’s wort) with cyclosporine A metabolism in a patient after liver transplantation Karliova M;Treichel U;Malago M(et al.)
  49. Gastroenterology v.113 Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes Fau D;Lekehal M;Farrel G(et al.)
  50. Hepatology v.32 Cytochrome P450generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes Haouzi D;Lekehal M;Moreau A(et al.)
  51. Public Health Nutr v.3 Hepatotoxicity fo botanicals Stickel F;Egerer G;Seitz HK.
  52. Gastroenterology v.106 Hepatotoxicity of germander in mice Loeper J;Descatoire V;Letteron P(et al.)
  53. AANA v.68 Hemorrhage after the preoperative use of complementary and alternative medicines Norred CL;Finlayson CA.
  54. Ann Intern Med v.135 Longterm trends in the use of complementary and alternative medicinal therapies in the United States Kessler RC;Davis RB;Foster DF(et al.)
  55. Hepatology v.34 Complementary and alternative medicine in the chronic liver disease Seef LB;Lindsay KL;Bacon BR(et al.)
  56. Hepatology v.30 Comparison of herbal therapy for liver disease:1996 versus 1999 Berk BS;Chaya C;Benner KC;Flora KD.
  57. J Trop Med v.95 Hospital admissions due to adverse reactions to Chinese herbal medicines Chan TYK;Chan AYW;Critchley JAJH.